Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial

Abstract

IntroductionChou-Ling-Dan (CLD) (Laggerapterodonta) granules are an ethnic herbal medicine from Yunnan province of China. CLD granules have been used for the treatment of inflammatory conditions and feverish diseases in China, including seasonal influenza, but few evidence-based medicine (EBM) clinical studies have been conducted to assess its efficacy and safety in the treatment of influenza. Here, we performed an EBM clinical trial combining Western Chinese medicine and traditional Chinese medicine (TCM) evaluation systems to evaluate the efficacy and safety of CLD granules in the treatment of seasonal influenza.Methods and analysisThe study is designed as a multicentre, randomised, double-blinded, double-simulation, oseltamivir-controlled and placebo-controlled, parallel-design clinical trial. Eligible subjects (n=318) will be allocated after satisfying the criteria (Western medicine). Subjects will be randomised to receive CLD granules, oseltamivir, or a placebo for 5 days of treatment and with follow-up after treatment to record symptoms and signs and to collect pharyngeal/throat swabs and serum samples for detecting the virus and antibodies. At the same time, the syndrome differentiation criteria of TCM, such as tongue body, furred tongue and type of pulse, will be recorded as determined by doctors of both Western and Chinese medicine. Participants will be instructed to comply with the protocol and to keep a daily record of symptoms. The primary and secondary outcomes and safety indicators will be used to evaluate the efficacy and safety of CLD granules in the treatment of seasonal influenza based on both Western Chinese medicine and TCM evaluation systems.Ethics and disseminationThe CLD granules clinical trial will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice and has been approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University. All participants must provide written informed consent. The results obtained will be disseminated at international medical conferences and in peer-reviewed publications.Trial registration numberNCT02662426; Pre-results.

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis

“…Among them, Lianhua Qingwen granules, Xiaoer Resuqing granules, and Xiaoer Shuanghuanglian mixture use Lonicera japonica (Thunb) and Forsythia suspensa (Thunb, Vahl) In future clinical practice, combination medications may provide new ideas to treat children with influenza, promoting the use of CPMs and TCM for this purpose (Ru et al, 2017;Gao and Wang, 2018;Liu et al, 2019). They are especially effective at shortening the time to fever resolution and relieving the symptoms of influenza Duan et al, 2011;Wang et al, 2011;He et al, 2019;Yoshino et al, 2019). This is consistent with the conclusions of the present study.…”

Efficacy of Guizhi Fuling Wan for Primary dysmenorrhea: protocol for a randomised controlled trial

“…Data will be collected from the dysmenorrhea daily of symptoms recorded by participants, the CRF tables, and TCM syndrome scores recorded by the trial team [31]. All patients will be invited to answer the data administrator's self-administered electronic questionnaire [32].…”

Traditional Chinese Medicine in Treating Influenza: From Basic Science to Clinical Applications

“…Also, Across-sectional study conducted in the Central Appalachian Region showed that Trigonella foenum-graecum L. was regularly used in treating Influenza (Alwhaibi et al, 2017). More and more RCTs are focusing on the efficacy and safety of combination use of TCM and conventional therapy (He et al, 2019). In summary, there is potential value in using TCM to treat influenza among children and pregnant women; nevertheless, more investigations are necessary for clinical validations.…”

“…Therefore, these challenges call for more effort and attention toward developing fresh strategies to combat influenza. Previously, TCM demonstrated a positive anti-viral effect on influenza virus and alleviated the symptoms among patients (He et al, 2019;Nagai et al, 2019). In TCM theory, influenza disease was classified as "YI Disease" and was first reported in Huang Di Nei Jing.…”